Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
06/21/2000 | EP1009430A1 Vaccines |
06/21/2000 | EP1009429A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
06/21/2000 | EP1009428A1 Vaginal suppository vaccine for urogenital infections |
06/21/2000 | EP1009420A1 Conjugates useful in the treatment of prostate cancer |
06/21/2000 | EP1009413A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
06/21/2000 | EP1009410A1 Method for producing stable acetylsalicylic acid solutions |
06/21/2000 | EP1009396A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
06/21/2000 | EP1009390A1 Prolonged anesthesia in joints and body spaces |
06/21/2000 | EP1009387A1 Stabilized sustained release tramadol formulations |
06/21/2000 | EP1009384A1 A method of administering liposomal encapsulated taxane |
06/21/2000 | EP1009381A1 Carotenoid microemulsions |
06/21/2000 | EP0825875B1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
06/21/2000 | EP0820304B1 Chlamydia vaccines |
06/21/2000 | DE19916224C1 Synthetic molecule for delivering active ingredient to cell, used e.g. to treat human immune deficiency virus infection, comprises the ingredient linked to VP2 or 3 peptide from polyoma virus |
06/21/2000 | DE19856443A1 Stabilisiertes Antithrombin III-Präparat Stabilized antithrombin III preparation |
06/21/2000 | CN1257431A Chemically and thermally stable norastemizole formulations |
06/21/2000 | CN1257425A Gastroretentive controlled release microspheres for improved drug delivery |
06/21/2000 | CN1257423A Preparation of powder agglomerates |
06/21/2000 | CN1257421A Medicinal aerosol products |
06/21/2000 | CN1053581C Yunnan Baiyao (white drug-powder) tablet and preparation method thereof |
06/21/2000 | CN1053570C Pharmaceutical composition of piperidinoalkanol-decongestant combination preparation process |
06/21/2000 | CN1053569C Injectable solution and process for preparing same |
06/20/2000 | US6077939 Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer |
06/20/2000 | US6077871 Droloxifene pharmaceutical compositions |
06/20/2000 | US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
06/20/2000 | US6077843 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
06/20/2000 | US6077835 Administering composition comprising compacted, unaggregated nucleic acid complexes, each complex consisting essentially of a single nucleic molecule encoding a protein and one or more carrier molecules to facilitate their uptake by target cells |
06/20/2000 | US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell |
06/20/2000 | US6077829 Comprising brain derived neurotrophic factor(bdnf), polyoxyethylene sorbitan monooleate as nonionic surfactant, and carrier; prevents denaturing and polymerization of bdnf; storage stability |
06/20/2000 | US6077714 Method for the preparation of free radical pharmaceuticals diagnostics and devices using selenium conjugates |
06/20/2000 | US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
06/20/2000 | US6077545 Photosensitive composition, acid generator and organosilicon compound |
06/20/2000 | US6077543 Atomizing solutions to produce drops; lung drug delivery |
06/20/2000 | US6077541 Enteric coating; capsules |
06/20/2000 | US6077539 Rapid bioavailability of metoclopramide; long acting non-steroidal antiinflammatory agent; free of ht3 receptor antagonists; side effect reduction |
06/20/2000 | US6077535 Sorbitol carrier |
06/20/2000 | US6077532 Pharmaceutical ion exchange resin composition |
06/20/2000 | US6077531 Capsule with micronized progesterone suspension in oil and estradiol in microspheres; menopause |
06/20/2000 | US6077529 Applying lipid transfer protein in aqueous solution to surface of lung and oronasal passage |
06/20/2000 | US6077528 Percutaneous preparation |
06/20/2000 | US6077523 Process to manufacture implants containing bioactive peptides |
06/20/2000 | US6077499 First conjugate of a tumor targeting moiety, a therapeutic agent, and first member of a binding pair; clearing agent; and second conjugate of the complementary binding member of the binding pair, and second therapeutic agent |
06/20/2000 | US6077232 Anticoagulant composition |
06/20/2000 | CA2169091C Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same |
06/20/2000 | CA2164619C Once-a-day metoprolol oral dosage form |
06/20/2000 | CA2144845C Germicidal detergent-iodine compositions having reduced detergent content |
06/20/2000 | CA2011262C Use of mixed micelles |
06/20/2000 | CA2000479C Vasopermeability-enhancing conjugates |
06/15/2000 | WO2000034451A1 Treatment of pompe's disease |
06/15/2000 | WO2000034444A2 Method and composition for preserving viruses |
06/15/2000 | WO2000034296A2 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same |
06/15/2000 | WO2000034293A1 Method for preparation of disodium pamidronate |
06/15/2000 | WO2000034246A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative |
06/15/2000 | WO2000034245A2 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
06/15/2000 | WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide |
06/15/2000 | WO2000033892A1 A medicinal aerosol formulation |
06/15/2000 | WO2000033888A2 Prodrug compounds and process for preparation thereof |
06/15/2000 | WO2000033887A2 Methods and formulations for reducing circulating antibodies |
06/15/2000 | WO2000033886A1 Dry powder complexes for gene delivery |
06/15/2000 | WO2000033885A1 Supramolecular complexes containing therapeutic agents |
06/15/2000 | WO2000033884A1 Conjugates of lipids and antimicrobial or antineoplastic drugs |
06/15/2000 | WO2000033883A1 Covalent polar lipid conjugates with antimicrobial and antineoplastic drugs for targeting to biological protected sites |
06/15/2000 | WO2000033882A1 A vi-repa conjugate vaccine for immunization against salmonella typhi |
06/15/2000 | WO2000033881A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
06/15/2000 | WO2000033880A2 Conjugate used for enriching in neuronal cells |
06/15/2000 | WO2000033879A1 Method for the treatment of inflammation |
06/15/2000 | WO2000033878A2 Stabilization of macrolides |
06/15/2000 | WO2000033877A1 Anhydrous topical skin preparations |
06/15/2000 | WO2000033874A2 Boron neutron capture therapy using pre-targeting methods |
06/15/2000 | WO2000033870A2 New cancer treatments |
06/15/2000 | WO2000033869A2 Use of human prostrate cell lines in cancer treatment |
06/15/2000 | WO2000033866A1 Pharmaceutical compositions containing insulin |
06/15/2000 | WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water |
06/15/2000 | WO2000033847A1 Micronized eplerenone compositions |
06/15/2000 | WO2000033835A1 Controlled-release dosage forms comprising zolpidem or a salt thereof |
06/15/2000 | WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction |
06/15/2000 | WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
06/15/2000 | WO2000033821A1 Enteric coated pravastatin bead formulation |
06/15/2000 | WO2000033820A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations |
06/15/2000 | WO2000033818A1 Sustained release tablet containing hydrocolloid and cellulose ether |
06/15/2000 | WO2000033817A1 Phospholipid compositions |
06/15/2000 | WO2000033815A1 Fungicide-containing powdery aerosol preparations |
06/15/2000 | WO2000033814A2 Method for administering agents to the central nervous system |
06/15/2000 | WO2000033813A1 Administration of neurotrophic agents to the central nervous system |
06/15/2000 | WO2000033811A2 Improvements in or relating to powders |
06/15/2000 | WO2000033810A1 Use of vitamin b12 in a nasal composition for delivering active agents to the central nervous system |
06/15/2000 | WO2000033809A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
06/15/2000 | WO2000033764A1 Biocompatible crosslinked polymers |
06/15/2000 | WO2000033636A1 Stabilization of ground plant seeds |
06/15/2000 | WO2000013672A9 New solid dose form of nanoparticulate naproxen |
06/15/2000 | WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
06/15/2000 | WO2000010536A8 Extended release buccal bioadhesive tablet |
06/15/2000 | WO2000010530A8 Oral liquid mucoadhesive compositions |
06/15/2000 | WO2000006244A3 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
06/15/2000 | WO1999066951A3 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
06/15/2000 | WO1998051278A3 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
06/15/2000 | DE19906977C1 Transdermal patch for administering deoxypeganin, useful for treating dementia-associated cognitive impairment and preventing intoxication by organic thiophosphate esters |
06/15/2000 | DE19857425A1 Liquid skin care product, useful e.g. for improving appearance of skin or delivering pharmaceuticals, separates quickly and sharply into oil and aqueous phases after shaking |
06/15/2000 | DE19857151A1 Powdered, water-soluble chlorhexidine salt, useful e.g. as disinfectant in cosmetics, contains anion from specific sugar acids or their lactones |
06/15/2000 | DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use |